Logo

GSK

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Moncef Slaoui Fired

The Wall Street Journal reports Moncef Slaoui has been fired from a biotech startup following allegations of sexual harassment.

Variant Vaccine Push

GlaxoSmithKline and CureVac have teamed up to develop a COVID-19 vaccine against multiple viral variants, Reuters reports.

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020

The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress

Oct 7, 2020

Nvidia Expands Genomics Activities With Supercomputer, New Partnerships
Premium

Jul 28, 2020

Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Premium

May 20, 2020

Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing
Premium

Apr 30, 2020

GSK Gets Broad Zejula Indication in Ovarian Cancer; FDA Deems Myriad Genetics' Test Complementary

Apr 8, 2020

Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK

Jan 23, 2020

Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

Oct 29, 2019

FDA Approval of Myriad Genetics CDx Adds HRD to Growing List of Ovarian Cancer Predictive Markers
Premium

Oct 28, 2019

Study Finds Residual Protein Expression Common After CRISPR Knockout

Oct 23, 2019

FDA Approves GSK's Zejula Alongside Myriad Genetics CDx for Advanced Ovarian Cancer

Sep 11, 2019

UK Biobank Whole-Genome Sequencing Project Obtains £200M from Pharma, Government, Philanthropy

Jun 24, 2019

SpeeDx, GSK Sign Test Supply, Development Deal

Jun 13, 2019

GlaxoSmithKline, UC's Doudna Establish $67M Genomics, CRISPR Research Lab

Apr 9, 2019

Myriad Submits MyChoice HRD as Companion Diagnostic for GSK's Zejula

Mar 25, 2019

UK Biobank to Make Whole-Genome Sequencing Data on 500K-Sample Repository Publicly Available
Premium

Jan 25, 2019

In Brief This Week: Illumina, Novacyt, Twist Bioscience, iGene Laboratory, More

Jul 26, 2018

GSK, 23andMe Gamble on Personalized Drug Discovery With Exclusive Deal
Premium

Jul 25, 2018

23andMe, GSK Ink Exclusive Drug Target Discovery Pact

Dec 6, 2017

UK Government Commits £210M to Grow Life Science Sector

Oct 12, 2017

NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative

Mar 23, 2017

GlaxoSmithKline, Regeneron Partner to Sequence Entire UK Biobank

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.